
Owkin is an AI biotech company focused on decoding complex biology to find the right treatment for every patient. Their core technology, Owkin K, is an agentic AI platform that integrates multimodal patient data with AI agents to accelerate drug discovery, development, and diagnostics. The company operates through specialized entities like Epkin (drug development), Owkin Dx (AI diagnostics), and Bioptimus (biology foundation model). Owkin leverages cutting-edge AI, including reinforcement learning, LLMs, and multimodal foundation models, with a strong emphasis on data access from a network of academic partners. They have strategic deals with Sanofi and BMS and are recognized for their contributions to AI in life sciences.

Owkin is an AI biotech company focused on decoding complex biology to find the right treatment for every patient. Their core technology, Owkin K, is an agentic AI platform that integrates multimodal patient data with AI agents to accelerate drug discovery, development, and diagnostics. The company operates through specialized entities like Epkin (drug development), Owkin Dx (AI diagnostics), and Bioptimus (biology foundation model). Owkin leverages cutting-edge AI, including reinforcement learning, LLMs, and multimodal foundation models, with a strong emphasis on data access from a network of academic partners. They have strategic deals with Sanofi and BMS and are recognized for their contributions to AI in life sciences.
Founded: 2016
Domain: Biotechnology research / AI-for-health
Core product: Owkin K agentic AI platform (multimodal, federated learning)
Notable investors: Sanofi (180M), GV, F-Prime, Bpifrance
Employee count (reported): 457
Accelerating drug discovery, clinical development, biomarker discovery, and diagnostic development by analyzing multimodal patient and biological data while preserving data privacy.
2016
Biotechnology Research
25,000,000
May 2020 extension reported as $25M, bringing that round's total to ~ $52–55M
180,000,000
Sanofi made a $180M equity investment and entered a strategic collaboration
Crunchbase and other records indicate a Series B closed in June 2022
| Company |
|---|
Owkin is an agentic AI company on a mission to explore complex biology to speed up and scale research for the creation of new treatments and diagnostics for patients. Owkin K, our AI co-pilot, combines unparalleled access to multimodal data, cutting-edge AI to understand biology, and pioneering agentic AI to achieve Biological Artificial Superintelligence in the future.
Owkin is comprised of a group of specialized companies that work seamlessly together, combining deep expertise with a shared mission to accelerate biological discovery. Owkin K serves as the technology foundation of our ecosystem, providing cutting-edge co-pilots that incorporate high-quality data infrastructure and AI tools to power breakthroughs for researchers, customers, and our companies.
Owkin has raised over $300 million through investments from leading biopharma companies, including Sanofi and BMS, and venture funds like Fidelity, GV, and Bpifrance, among others. Owkin is seeking the best and brightest to join our fast-growing and dynamic team.
Job Title: Data Engineer
Location: Paris - Nantes - Remote in France
Employment Type: Full-time
Department: R&TECH
As a Data Engineer, you will be part of the Engineering team, supporting the development and maintenance of data pipelines for scientific processing and quality assurance. Your primary responsibilities will include:
Please submit your CV in English. Owkin is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, sex, gender, sexual orientation, age, color, religion, national origin, protected veteran status, or on the basis of disability.